In 1974, at the age of 20, Li Xianyu graduated from high school to a watercourse instrumentation factory in Wenling as a screw salesman, this dry is ten spring and fall.
Traveling around the world, so that the young Li Xianyu tasted life's sweet and sour, to experience the human condition. But more importantly, all the way line, all the way to think, so that Li Xianyu preliminary grasp of the laws of the market. In the subsequent entrepreneurial experience, Li Xianyu face the complexity of the market phenomenon, many times to accurately make judgments, and quickly out of the predicament towards success.
In the 1980s, Huangyan mold industry began to take off. Seeing this industry towards prosperity, Li Xianyu cobbled together 30,000 yuan, rented a private room, the production of daily-use plastics and molds. 1984 8 years, Li Xianyu founded the first enterprise - Huangyan County Plastic Color Printing Factory was officially established. This is a small enterprise, even Li Xianyu less than ten people.
Early in 1988, Li Xianyu went to Shanghai to do business, took the time to find an old friend - Shanghai Huashan Hospital professor to catch up. He didn't realize that an important turning point in his life and career would begin with this meeting with an ordinary friend.
That year, there was a major outbreak of hepatitis A in Shanghai, which became a hot issue for people. During the conversation, the professor said that after the outbreak of hepatitis A, disposable sterile syringes became the most scarce items in major hospitals and needed to be imported in large quantities. And from the development trend of health care, disposable medical devices will become the mainstream of hospital use in the future.
Li Xianyu keenly realized that this is a rare business opportunity. A bold idea began to breed in his mind - industrial transformation, the production of disposable medical equipment.
Li Xianyu has always done things quickly, and the afternoon after the meeting with the professor, he inquired about the Shanghai Syringe Factory, and found the deputy director of the syringe factory, boldly put forward to him the idea of joint production of disposable syringes. Shanghai Syringe Factory was a powerful state-run factory, but at that time, it only produced syringes with glass barrels, and the deputy factory director expressed interest in Li Xianyu's idea. Two days later, the factory sent a special engineer to Huangyan for inspection. After a period of inspection, Huangyan mold town's reputation as well as Li Xianyu that growing enterprise began to impress the engineer's heart.
Just when everything was getting good, an inexplicable pressure ensued. It turned out that Li Xianyu's idea was opposed by many people, including the leadership of the competent departments also raised objections: the project is not only a large investment, but also difficult, if there is a mistake, it is not a loss of a wife and a soldier?
On or off? This problem plagued Li Xianyu all night. On, means that the enterprise to accept the serious challenge, perhaps blood money; not on, can steadily develop, but the enterprise may always traveling in the slow lane. Considering the brilliant prospect of disposable syringes, Li Xianyu made a decisive decision to switch to the production of disposable sterile syringes.
After the joint venture with Shanghai Syringe Factory, Li Xianyu founded the Huangyan branch of Shanghai Syringe Factory and registered the trademark "Double Pigeon". Li Xianyu said: "Later rumors spread that I had two daughters, so the name 'Double Pigeon', in fact, this is not the meaning. At that time, Shanghai Syringe Factory's 'Pigeon' brand syringes were famous throughout the country, and 'Double Pigeon' meant that the big pigeon led the little pigeon to fly together."
Today, the big pigeon is forever remembered, while the little pigeon thrives and spreads its wings.
In the summer of 1991, the Sino-Russian border trade was very hot, and it became a direction of concern for enterprises. One day, a salesman based in Harbin sent a fax that a foreign trade company in Heilongjiang province wanted to buy more than 3 million yuan worth of syringes. This bulk order, to be vigorously expanding the market Li Xianyu with great encouragement. He immediately deployed troops and organized staff to work overtime, and shipped the products to Harbin within the period specified in the contract.
However, the sky is the limit, due to changes in the situation of China-Russia border trade, foreign trade companies temporarily change their minds, and product quality is not good as the reason, refused to pay the purchase price. Li Xianyu was enraged, a paper to the other party sent to the defendant.
This setback, so that the wings are still tender "double pigeon" just spread their wings to fly on the heavy fall to the ground. Li Xianyu began to calmly analyze the Chinese market. At that time, the north of China's consumption level is not high, many provincial hospitals are still relatively poor medical conditions. In the south, on the other hand, economic development was vibrant, and people's consumption concepts were at the forefront. Thus, Li Xianyu shifted his sales focus from the north to the south, choosing Guangdong as the breakthrough in the domestic market.
At that time, there were more than 60 enterprises producing syringes like "Double Pigeon" in China. In the Guangdong market, Li Xianyu's joint venture played a role. Because the Shanghai syringe factory's "pigeon" brand also has a certain degree of popularity in Guangdong, this big pigeon soon led the "double pigeon" into the Guangdong market.
In the first year, "Double Pigeon" sold 7 million syringes in Guangdong, and in the second year, the sales jumped seven times to 49 million, and by 1998, the Guangdong market consumed 170 million syringes of "Double Pigeon" brand annually, accounting for more than 75% of the company's domestic sales. By 1998, the Guangdong market consumed 170 million syringes per year, accounting for more than 75% of the company's domestic sales. It can be said that among the syringes used in Guangdong hospitals, 3 out of 5 are produced by "Double Pigeon".
If the switch to syringes rewrote Li Xianyu's life and the history of the company he founded, then the choice of Guangdong as a breakthrough in the domestic market was a red carpet for the development of "Double Pigeon" by Li Xianyu. In the Asian financial turmoil, the Guangdong market even became a "double pigeon" shelter.
In 1998, Double Pigeon Group took the lead in the domestic counterparts through the ISO9002 and CE certification, also has a high market share in the country. Precisely because Double Pigeon brand products sell well in the domestic market, they also become the object of counterfeiting by some unscrupulous elements in China.
In 1997, Guangzhou found counterfeit "Double Pigeon" brand products, in 1998, Chongqing, Kunming found counterfeit products, in 1999, Hainan found counterfeit "Double Pigeon" brand products. Counterfeit "Double Pigeon" fish eyes mixed up a large number of influx into the market, damaged the "Double Pigeon" product reputation, but also directly affected the "Double Pigeon" marketing. Double Pigeon Group for this special organization to fight the group, to the country to fight counterfeiting, but the results are very little.
At this point, Li Xianyu put forward a different point of view, the fake is fake, it will not steal the authentic brand's rice bowl. On the contrary, the top of the "Double Pigeon" brand flaunted in the market, invariably also help "Double Pigeon" to do a free advertising.
In 2000, the state listed disposable sterile syringes and infusion sets as the focus of the domestic market, forming a nationwide high-pressure situation to combat counterfeiting, and the three major domestic counterfeiting bases were cleared. The market occupied by counterfeits was empty, and "Double Pigeon" seized this rare opportunity and easily captured the market.
Sitting in front of Li Xianyu's wide desk, he took out a sample syringe and put it in front of the reporter. It is not a syringe with a needle, looking at the plastic parts, the reporter more or less contempt.
Li Xianyu thinks otherwise. He said that the syringe from the needle, syringe to the inside of the gasket are "double pigeon" people independent research and development and production. For example, the needle, too blunt, the patient will be painful when the needle, such as gaskets, if the difference is not even a fraction of a second, it will not be sealed.
In 2003, Li Xianyu led experts to develop two high-tech projects. One is the automatic production line for non-PVC I.V. bags. To import such equipment from Germany would cost at least 20 million yuan, which is a considerable investment. Compared with the traditional infusion bottles, non-PVC I.V. soft bags have the advantages of easy shipment, aseptic safety, etc., is a good alternative to bottled infusion products and development direction.
Giving up this project, that is impossible. Imported more than 20 million production line, Li Xianyu and "in the heart". Not as good as their own hands to build, Li Xianyu came up with a bold idea. He led the technical staff from South Korea, India and other countries to import related equipment, and play the local advanced plastic molding technology, integration of more than a year, and finally debugged a fully automatic production line. As long as the plastic film, dozens of seconds a bag of infusion soft bags "go" out. A price, the production line only 7 million yuan.
Another high-tech project is the safety syringe. This product will be the mainstream of the future of disposable syringes, the product has a self-destruct function, which can be conducive to recycling, to avoid the influx of society, in particular, to avoid being reused by drug patients. The existing 36 states in the United States through legislation, the use of such safety syringes must be used, the annual U.S. usage reached 2 billion.
"Double Pigeon" began to implement the "enhancement of international competitiveness" project, began research and development of a new generation of safety syringes to meet the market. "The safety syringes produced by Double Pigeon have a self-destruct function where the needle shrinks into the barrel after use.
A U.S. company began researching and developing this product in 2002, but for technical reasons, it has not been able to realize mass production. "Double Pigeon" and its cooperation, only two months time to solve a series of technical problems, and successfully put the product on the market. The stock of this American company was sold at 6 dollars per share, but due to the lack of success of the product, the stock dropped to 3 dollars. When Wall Street learned that the company had partnered with China's "Double Pigeon" and achieved R&D success, the stock immediately rebounded. The company's stock has risen to $7.
In the interview, Li said Bruce, president of Australia's OMI, had told him the day before that a project between the two companies had been a major success, which meant another solid step forward for Double Pigeon's overseas strategy.
Li Xianyu said: "The processing of materials can not really improve the international competitiveness of enterprises. Enhance research and development capabilities, develop products with independent property rights, which is the real core competitiveness of enterprises."
In May 2008, the group invested in the formation of "Zhejiang Double Pigeon New Energy Co., Ltd." to enter the new photovoltaic energy industry; the company's registered capital of 50 million yuan, with a total planned investment of 300 million yuan. The main equipment invested in the first phase of the solar panel module imported two production lines, 90 sets of monocrystalline silicon production equipment, the U.S. GT polysilicon casting and anchoring equipment 10 sets, 10 sets of HCT slicer, the plan is to produce annual output of 150 megawatts of solar cells.